Investigational Drug Information for Landiolol
✉ Email this page to a colleague
What is the development status for investigational drug Landiolol?
Landiolol is an investigational drug.
There have been 10 clinical trials for Landiolol.
The most recent clinical trial was a Phase 3 trial, which was initiated on December 13th 2019.
The most common disease conditions in clinical trials are Atrial Fibrillation, Shock, Septic, and Tachycardia. The leading clinical trial sponsors are University Hospital, Caen, Medical University of Vienna, and AOP Orphan Pharmaceuticals AG.
There are two hundred and forty-five US patents protecting this investigational drug and two international patents.
Summary for Landiolol
| US Patents | 245 |
| International Patents | 2,960 |
| US Patent Applications | 896 |
| WIPO Patent Applications | 405 |
| Japanese Patent Applications | 228 |
| Clinical Trial Progress | Phase 3 (2019-12-13) |
| Vendors | 24 |
Recent Clinical Trials for Landiolol
| Title | Sponsor | Phase |
|---|---|---|
| Landiolol for Prevention of Postoperative Atrial Fibrillation in Patients Undergoing Cardiac Surgery | Medical University of Vienna | Phase 3 |
| LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS) | Assistance Publique - Hôpitaux de Paris | Phase 3 |
| Beta-blockade With Landiolol in Out-of-hospital Cardiac Arrest | Medical University of Vienna | Phase 1/Phase 2 |
Clinical Trial Summary for Landiolol
Top disease conditions for Landiolol
Top clinical trial sponsors for Landiolol
US Patents for Landiolol
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Landiolol | ⤷ Try a Trial | Branched 3-phenylpropionic acid derivatives and their use | BAYER PHARMA AKTIENGESELLSCHAFT (Monheim, DE) | ⤷ Try a Trial |
| Landiolol | ⤷ Try a Trial | Substituted pyridobenzodiazepinone-derivatives and use thereof | Bayer Pharma Aktiengesellschaft (Berlin, DE) | ⤷ Try a Trial |
| Landiolol | ⤷ Try a Trial | Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their use | BAYER PHARMA AKTIENGESELLSCHAFT (Berlin, DE) | ⤷ Try a Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Landiolol
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Landiolol | African Regional IP Organization (ARIPO) | AP3482 | 2031-04-13 | ⤷ Try a Trial |
| Landiolol | Argentina | AR085586 | 2031-04-13 | ⤷ Try a Trial |
| Landiolol | Australia | AU2012242122 | 2031-04-13 | ⤷ Try a Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
